Updated

Researchers found that an experimental compound called AP503 significantly strengthened bones in mice by activating the GPR133 receptor, which boosts bone formation while slowing bone loss. The treatment has also been linked to stronger muscles, raising interest in its potential against age-related decline and osteoporosis.